Inflation Reduction Act IRA requires drug manufacturers to pay rebates to Medicare when prices of Part B and Part D prescription drug increase faster than inflation. CMS announced first 27 Part B drugs, biological products prescription drugs with adjusted coinsurance rates.
The Inflation Reduction Act (the “IRA”) requires drug manufacturers to pay rebates to Medicare when the prices of their Part B and Part D prescription drug increase faster than the rate.
Centers for Medicare and Medicaid Services CMS released two highly-anticipated guidance documents detailing the agency’s proposed implementation of the Medicare Part B and Medicare Part D Prescription Drug Inflation Rebate Programs.
On February 9, 2023, the Centers for Medicare and Medicaid Services (“CMS”) released two highly-anticipated guidance documents (the “Guidance”) detailing the agency’s proposed.